Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Emerging Immunotherapy Options for BCG-unresponsive Non-muscle-invasive Bladder Cancer.

Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC.

J Urol. 2019 May 1:101097JU0000000000000297. doi: 10.1097/JU.0000000000000297. [Epub ahead of print]

PMID:
31042108
2.

Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients.

Reyblat P, Chan KG, Josephson DY, Stein JP, Freeman JA, Grossfeld GD, Esrig D, Ginsberg DA.

World J Urol. 2009 Feb;27(1):63-8. doi: 10.1007/s00345-008-0351-3. Epub 2008 Nov 20.

PMID:
19020878
3.

Fine needle aspiration cytology of adult perineal rhabdomyosarcoma: a case report.

Meng MV, Grossfeld GD, Sudilovsky D, Baehner FL.

Acta Cytol. 2006 Jan-Feb;50(1):88-92.

PMID:
16514847
4.

Treatment and outcome of invasive bladder cancer in patients after renal transplantation.

Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR.

J Urol. 2004 Mar;171(3):1085-8. Review.

PMID:
14767276
6.

Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.

Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR.

Urology. 2003 Dec;62(6):1035-9.

PMID:
14665350
7.

Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.

Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP.

J Urol. 2003 Nov;170(5):1822-7.

PMID:
14532784
8.

Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy.

Meng MV, Shinohara K, Grossfeld GD.

Urol Oncol. 2003 Mar-Apr;21(2):145-51. Review.

PMID:
12856644
9.

National practice patterns and time trends in androgen ablation for localized prostate cancer.

Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR.

J Natl Cancer Inst. 2003 Jul 2;95(13):981-9.

10.

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE.

Urology. 2003 Jan;61(1):190-6.

11.

Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.

Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, Grossfeld GD, Cunha GR, Hayward SW.

Prostate. 2003 Feb 15;54(3):212-9.

PMID:
12518326
12.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
13.

Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2002 Dec;168(6):2510-5.

PMID:
12441951
14.

Surgery for prostate cancer: rationale, technique and outcomes.

Downs TM, Kane CJ, Grossfeld GD, Meng MV, Carroll PR.

Cancer Metastasis Rev. 2002;21(1):29-44. Review.

PMID:
12400995
15.

Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.

Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR.

J Urol. 2002 Nov;168(5):2092-6.

PMID:
12394716
16.

A review of measurement of patient preferences for treatment outcomes after prostate cancer.

Lubeck DP, Grossfeld GD, Carroll PR.

Urology. 2002 Sep;60(3 Suppl 1):72-7; discussion 77-8. Review.

PMID:
12231054
17.

Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy.

Grossfeld GD, Li YP, P Lubeck DP, Carroll PR.

Urology. 2002 Sep;60(3 Suppl 1):57-62; discussion 62-3. Review.

PMID:
12231051
18.

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.

Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR.

Urology. 2002 Sep;60(3 Suppl 1):7-11; discussion 11-2.

PMID:
12231037
19.

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.

Carroll PR, Kantoff PW, Balk SP, Brown MA, D'amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, Mcleod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C; Second International Conference on Newer Approaches to Androgen Deprivation Therapy (ADT) in Prostate Cancer.

Urology. 2002 Sep;60(3 Suppl 1):1-6. Review. No abstract available.

PMID:
12231036
20.

Neoadjuvant strategies for prostate cancer prior to radical prostatectomy.

Meng MV, Grossfeld GD, Carroll PR, Small EJ.

Semin Urol Oncol. 2002 Aug;20(3 Suppl 1):10-8. Review.

PMID:
12198633
21.
22.
23.

Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy.

Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll PR.

Urology. 2002 May;59(5):709-14.

PMID:
11992845
24.

Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.

Master VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD.

J Urol. 2002 Jun;167(6):2521-2. No abstract available.

PMID:
11992074
25.

Simultaneous laparoscopic management of 3 urological malignancies.

Deng DY, Meng MV, Grossfeld GD, Stoller ML.

J Urol. 2002 May;167(5):2125-6. No abstract available.

PMID:
11956456
26.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
27.
28.

Renal carcinoma after laparoscopic cyst decortication.

Meng MV, Grossfeld GD, Stoller ML.

J Urol. 2002 Mar;167(3):1396. No abstract available.

PMID:
11832747
29.
30.

The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis.

Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T.

Cancer Res. 2001 Nov 15;61(22):8143-9.

31.

Malignant transformation in a nontumorigenic human prostatic epithelial cell line.

Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR.

Cancer Res. 2001 Nov 15;61(22):8135-42.

32.

Extramammary Paget's disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy.

Park S, Grossfeld GD, McAninch JW, Santucci R.

J Urol. 2001 Dec;166(6):2112-6; discussion 2117.

PMID:
11696717
33.

Prostate cancer early detection: a clinical perspective.

Grossfeld GD, Carroll PR.

Epidemiol Rev. 2001;23(1):173-80. Review. No abstract available.

PMID:
11588845
34.

Orthotopic urinary diversion with the ileal neobladder.

Grossfeld GD, Carroll PR.

Tech Urol. 2001 Sep;7(3):196-202. Review.

PMID:
11575516
35.

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD.

Clin Cancer Res. 2001 Sep;7(9):2712-8.

36.
37.

The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.

Lubeck DP, Grossfeld GD, Carroll PR.

Urology. 2001 Aug;58(2 Suppl 1):94-100. Review.

PMID:
11502459
38.

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.

Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR.

Urology. 2001 Aug;58(2 Suppl 1):56-64. Review.

PMID:
11502450
39.

Overview consensus statement.

Carroll PR, Fair WR, Grossfeld GD, Heston WD, Lieberman R, Malkowicz SB, Stricker HJ, Sylvester J, Peehl DM, Meyer F, Hart C.

Urology. 2001 Aug;58(2 Suppl 1):1-4. No abstract available.

PMID:
11502434
40.

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.

Grossfeld GD, Chaudhary UB, Reese DM, Carroll PR, Small EJ.

Urology. 2001 Aug;58(2):240-5.

PMID:
11489710
41.

Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?

Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR.

J Urol. 2001 Jul;166(1):111-5.

PMID:
11435834
42.

Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.

Park S, Shinohara K, Grossfeld GD, Carroll PR.

J Urol. 2001 May;165(5):1409-14.

PMID:
11342887
43.
44.

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.

Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR.

Urology. 2001 Apr;57(4):599-603. No abstract available.

PMID:
11306356
45.

Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.

Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR.

Am Fam Physician. 2001 Mar 15;63(6):1145-54. Review.

46.
47.
48.

Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.

Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll PR.

Urology. 2000 Sep 1;56(3):430-5.

PMID:
10962308
49.

Management of a positive surgical margin after radical prostatectomy: decision analysis.

Grossfeld GD, Tigrani VS, Nudell D, Roach M 3rd, Weinberg VK, Presti JC Jr, Small EJ, Carroll PR.

J Urol. 2000 Jul;164(1):93-9; discussion 100. Review.

PMID:
10840431
50.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR.

J Urol. 2000 Jul;164(1):81-8.

PMID:
10840429

Supplemental Content

Loading ...
Support Center